Precision Medicine
Workforce
The partnership will use de-identified patient data to zero in on factors that worsen COVID-19 outcomes among certain groups.
S4S pilot project participants noted that research requirements can affect the ability to adopt third-party apps, among other barriers to broader adoption of patient-directed data sharing.
HIMSS Middle East 2020
Both will work together to accelerate the growth of transformational healthcare companies across markets in the Middle East and North African, and the Association of South-East Asian Nations.
Working with AWS, researchers from UPMC, the University of Pittsburgh, and Carnegie Mellon are building new machine learning tools for breast cancer and depression screening.
SPONSORED
HIMSS Europe 2020
Measuring and managing Multiple Sclerosis: could digital assessment tools improve our understanding?
The extent to which the world of digital health has changed during the COVID-19 pandemic has been widely recognised.
The ADT-based collaboration network will collaborate with the Hospital Industry Data Institute to support delivery of near real-time data to Missouri care teams.
HIMSS Europe 2020
Shifting the focus from acute to preventative health and care is the ultimate aim for the digital transformation of health systems globally. Precision health integrates health insights and social determinants to improve clinical and financial outcomes.
Dragon Medical One voice technology will be integrated with mCODE core data, enabling easier documentation within clinical workflows – and a new partnership with Mayo will explore automation opportunities.
Health and care have been inexorably moving toward a new paradigm – one where the nature of the interactions is more personalised and they require the person to be more active in their pursuit of reducing risks that have an adverse effect upon the development of non-communicable diseases, says Dr Charles Alessi, chief clinical officer at HIMSS.
The U.S. Department of Health and Human Services also announced it would give $450 million to the biotech company Regeneron to manufacture and supply the company's antibody treatment.